Beneficial effects of fucoidan in patients with chronic hepatitis C virus infection

doi:10.3748/wjg.v18.i18.2225

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 18

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4933)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

494

HTML

4020

Figures (1-2)

216

Tables (1-1)

203

Sum=4933

May 14, 2012 (publication date) through Nov 30, 2024

Times Cited of This Article

Times Cited (36)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 14, 2012; 18(18): 2225-2230
Published online May 14, 2012. doi: 10.3748/wjg.v18.i18.2225

Full Size Figure Download Figure

Figure 1 Anti-hepatitis C virus effects of fucoidan in hepatitis C virus replicon cells. Luciferase (LUC) activity (a marker of replication level) and cell viability of FLR3-1 cells, which constitutively express hepatitis C virus replicon, were measured in the presence of various concentrations of fucoidan. LUC and WST-8 assays were performed in triplicate. Data are mean ± SD.

Citation: Mori N, Nakasone K, Tomimori K, Ishikawa C. Beneficial effects of fucoidan in patients with chronic hepatitis C virus infection. World J Gastroenterol 2012; 18(18): 2225-2230
URL: https://www.wjgnet.com/1007-9327/full/v18/i18/2225.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i18.2225